OSE Immunotherapeutics SA
EPA:OSE.PA
7.5 (EUR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||
Current Assets: | ||||||||||||
Cash & Cash Equivalents
| 18.672 | 25.62 | 33.579 | 29.368 | 25.842 | 9.573 | 9.646 | 14.885 | 9.332 | 1.111 | 0.28 | 0.185 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 2.861 | 2.882 | 2.881 | 5.801 | 0 | 0 | 0 |
Cash and Short Term Investments
| 18.672 | 25.62 | 33.579 | 29.368 | 25.842 | 12.434 | 12.528 | 17.766 | 15.133 | 1.111 | 0.28 | 0.185 |
Net Receivables
| 9.061 | 8.128 | 7.663 | 7.968 | 5.433 | 2.253 | 0.127 | 12.323 | 0.434 | 0.593 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.435 | 0 | 0 | 0 |
Other Current Assets
| 2.745 | 3.452 | 2.964 | 2.496 | 1.787 | 8.337 | 11.331 | 6.449 | 1.309 | 0.223 | 0.028 | 0.031 |
Total Current Assets
| 30.478 | 37.2 | 44.206 | 39.832 | 33.062 | 23.024 | 23.986 | 36.538 | 16.876 | 1.927 | 0.308 | 0.254 |
Non-Current Assets: | ||||||||||||
Property, Plant & Equipment, Net
| 4.07 | 4.979 | 5.439 | 3.795 | 2.701 | 0.904 | 0.429 | 0.11 | 0.065 | 0.025 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 46.401 | 48.784 | 51.122 | 52.6 | 52.6 | 52.6 | 52.6 | 52.6 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 46.401 | 48.784 | 51.122 | 52.6 | 52.6 | 52.6 | 52.6 | 52.6 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0.756 | 0.524 | 0.581 | 0.455 | 0.244 | 0.077 | -52.432 | 0.099 | 0 | 0 | 0.028 | 0 |
Tax Assets
| 0.195 | 0.183 | 0.173 | 0.165 | 0.283 | 0.272 | 0.261 | 0.157 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0 | 0 | -0 | 0 | -52.949 | -0.429 | -52.856 | -0.065 | -0.025 | -0.028 | 0 |
Total Non-Current Assets
| 51.422 | 54.47 | 57.315 | 57.015 | 55.828 | 0.904 | 0.429 | 0.11 | 0.065 | 0.025 | 0.028 | 0.028 |
Total Assets
| 81.9 | 91.67 | 101.521 | 96.847 | 88.89 | 76.903 | 77.353 | 89.547 | 16.995 | 1.98 | 0.336 | 0.282 |
Liabilities & Equity: | ||||||||||||
Current Liabilities: | ||||||||||||
Account Payables
| 6.36 | 4.563 | 2.955 | 7.389 | 4.284 | 6.555 | 8.776 | 4.256 | 1.129 | 1.518 | 0.026 | 0.006 |
Short Term Debt
| 7.261 | 3.976 | 2.367 | 0.644 | 0.857 | 0.628 | 0.589 | 0.587 | 0.776 | 0.284 | 0 | 0 |
Tax Payables
| 0.02 | 0.021 | 0.014 | 0.002 | 0.02 | 0.086 | 0.001 | 0.008 | 0.005 | 0.002 | 0.003 | 0.008 |
Deferred Revenue
| 0.347 | 0.812 | 1.046 | 1.087 | 4.811 | 0.574 | 4.07 | 10.664 | 0.098 | -0.284 | 0 | 0 |
Other Current Liabilities
| 4.831 | 6.917 | 10.394 | 5.008 | 4.378 | 1.318 | 1.062 | 3.156 | 0.302 | 0.371 | 0.027 | 0.078 |
Total Current Liabilities
| 18.799 | 16.268 | 16.762 | 14.128 | 14.33 | 9.075 | 14.497 | 18.663 | 2.305 | 1.889 | 0.053 | 0.084 |
Non-Current Liabilities: | ||||||||||||
Long Term Debt
| 35.508 | 37.231 | 30.801 | 16.552 | 9.211 | 3.832 | 4.296 | 1.197 | 0.204 | 0.894 | 1.147 | 0.831 |
Deferred Revenue Non-Current
| 3.032 | 3.586 | 3.965 | 2.318 | 1.413 | 1.822 | 1.43 | -3.806 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 1.311 | 1.514 | 1.748 | 2.08 | 5.066 | 2.01 | 2.866 | 5.003 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0.429 | 0.524 | 0.71 | 0.531 | 0.377 | -3.832 | -4.296 | -1.197 | -0.204 | -0.894 | -1.147 | -0.831 |
Total Non-Current Liabilities
| 40.28 | 42.855 | 37.224 | 21.481 | 16.067 | 3.832 | 4.296 | 1.197 | 0.204 | 0.894 | 1.147 | 0.831 |
Total Liabilities
| 59.079 | 59.123 | 53.986 | 35.609 | 30.397 | 15.149 | 21.907 | 25.022 | 2.519 | 2.783 | 1.2 | 0.915 |
Equity: | ||||||||||||
Preferred Stock
| 3.43 | 0 | 0 | 0 | 0 | 0.057 | 0.016 | 0 | 2.64 | 1.273 | 0.278 | 0 |
Common Stock
| 4.33 | 3.705 | 3.705 | 3.597 | 3.001 | 2.963 | 2.898 | 2.858 | 2.01 | 1.605 | 0.527 | 0.527 |
Retained Earnings
| -57.281 | -35.889 | -21.11 | -7.485 | 34.113 | 5.49 | -10.503 | 20.666 | -5.584 | -2.835 | -0.25 | -1.436 |
Accumulated Other Comprehensive Income/Loss
| -0.309 | -0.22 | -0.15 | -0.104 | -0.1 | -0.057 | -0.016 | 26.746 | -2.64 | -1.273 | -1.142 | 0 |
Other Total Stockholders Equity
| 72.651 | 64.951 | 65.09 | 65.23 | 21.479 | 53.301 | 63.051 | 14.255 | 18.05 | 0.427 | -0.277 | 0.909 |
Total Shareholders Equity
| 22.821 | 32.547 | 47.535 | 61.238 | 58.493 | 61.754 | 55.446 | 64.525 | 14.476 | -0.803 | -0.864 | -0.633 |
Total Equity
| 22.821 | 32.547 | 47.535 | 61.238 | 58.493 | 61.754 | 55.446 | 64.525 | 14.476 | -0.803 | -0.864 | -0.633 |
Total Liabilities & Shareholders Equity
| 81.9 | 91.67 | 101.521 | 96.847 | 88.89 | 76.877 | 77.318 | 89.547 | 16.995 | 1.98 | 0.336 | 0.282 |